Gelteq (GELS) Equity Average (2024)
Gelteq (GELS) recorded quarterly Equity Average of $11.2 million in Q2 2024.
Gelteq (GELS) Equity Average (2024) Analysis & Trends
Gelteq's Equity Average history runs 1 years deep, the most recent figure standing at $11.2 million for Q2 2024.
- In Q2 2024, Equity Average changed N/A year-over-year to $11.2 million; the TTM figure through Jun 2024 stood at $11.2 million (changed N/A YoY), while the FY2025 annual figure was $10.0 million, down 10.47% from the prior year.
- Equity Average was $11.2 million for Q2 2024 at Gelteq.
- In the past five years, Equity Average ranged from a high of $11.2 million in Q2 2024 to a low of $11.2 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Gelteq | 10.57 Mn | 10.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 11.21 Mn |